Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 70

JD Health jets towards IPO

JD.com’s healthcare spinoff has filed for an initial public offering after raising more than $1.9bn in equity funding from investors including Hillhouse Capital and Citic Capital.

Sep 30, 2020

Taysha rakes in $181m from public listing

UT Southwestern-founded Taysha Gene Therapies surpassed its goal after underwriters bought additional shares.

Sep 29, 2020

Logicreation thinks through $152m IPO

Tencent and Heyi Group are among the investors in line for an exit as Logicreation files to go public in China.

Sep 29, 2020

Ninebot to drift into $295m IPO

Xiaomi and Intel-backed e-scooter vendor Ninebot is gearing up for a $295m initial public offering on the Star Market using Chinese Depository Receipts.

Sep 25, 2020

Miniso to go big on NYSE

Tencent-backed low-cost retailer Miniso has put a $100m placeholder figure in its filing for an IPO, more than a year after its plans first emerged.

Sep 25, 2020

Zhonggu Logistics to move onto stock exchange

Zhonggu Logistics has filed for a $218m on the Shanghai Stock Exchange, providing exits to Zhonggu Shipping and SoftBank.

Sep 22, 2020

Athira attains $204m IPO

The Washington State University neurological drug developer has gone public after issuing 12 million shares priced at $17 each.

Sep 21, 2020

Compass Pathways navigates IPO

Compass Pathways has raised more than $127m in an upsized initial public offering that provided an exit to Otsuka Pharmaceuticals.

Sep 21, 2020

Analysis: Snowflake goes public

Data management software provider Snowflake, which counts Salesforce among its backers, has gone public and its price doubled on the first day of trading.

Sep 21, 2020

Amwell rams its way to $742m IPO

The telehealth system provider is going public in an $742m upsized offering that will enable Philips, Allianz, Teva and Takeda to exit.

Sep 18, 2020
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here